Board Member
Rhythm Pharmaceuticals, Inc. (RYTM)Board Member
Trevi Therapeutics, Inc. (TRVI)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2025-06-11–present
Recorded roles and earnings-call appearances connecting this person to public companies.
CEO, Board Member
2025-06-11–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Trevi Therapeutics, Inc. (TRVI) | President and Chief Executive Officer | $622,382 | $3,944,892 |
| 2024 | Trevi Therapeutics, Inc. (TRVI) | President and Chief Executive Officer | $607,930 | $2,589,035 |
| 2023 | Trevi Therapeutics, Inc. (TRVI) | President and Chief Executive Officer | $596,924 | $1,687,298 |
| 2022 | Trevi Therapeutics, Inc. (TRVI) | President and Chief Executive Officer | $523,182 | $898,095 |
| 2021 | Trevi Therapeutics, Inc. (TRVI) | President and Chief Executive Officer | $505,961 | $1,527,439 |
| 2020 | Trevi Therapeutics, Inc. (TRVI) | President and Chief Executive Officer | $477,692 | $1,441,457 |
| 2019 | Trevi Therapeutics, Inc. (TRVI) | President and Chief Executive Officer | $434,615 | $2,810,719 |
| 2018 | Trevi Therapeutics, Inc. (TRVI) | President and Chief Executive Officer | $400,000 | $528,250 |
Earnings-call appearances and filed executive appointments or departures, newest first.
